Cabergoline
NDC 59762-1005, cabergoline, tablet, from Mylan Pharmaceuticals Inc..
- Product NDC
- 59762-1005
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA020664
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59762-1005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CABERGOLINE.5 mg/1
Pharmacologic classes
Ergolines [CS]; Ergot Derivative [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59762-1005-1 | 59762100501 | 8 TABLET in 1 BOTTLE (59762-1005-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e497366b-a124-4d7f-bd45-a883c392d4bbNADAC price for package 59762100501
GET /v1/drugs/nadac/59762100501
Use it
Look up 59762-1005 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59762-1005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59762-1005. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.